Rainer Müller

Active 1980–2025

Also published as
Rainer Muller
231
Papers
39,524
Citations
108
h-index
181
i10-index

Citations

Citations per year for Rainer Müller1989: 4 citations1990: 1 citations1991: 7 citations1992: 5 citations1993: 4 citations1994: 11 citations1995: 16 citations1996: 25 citations1997: 25 citations1998: 28 citations1999: 33 citations2000: 56 citations2001: 69 citations2002: 73 citations2003: 118 citations2004: 182 citations2005: 225 citations2006: 210 citations2007: 451 citations2008: 398 citations2009: 433 citations2010: 468 citations2011: 585 citations2012: 638 citations2013: 540 citations2014: 616 citations2015: 475 citations2016: 510 citations2017: 462 citations2018: 567 citations2019: 1,346 citations2020: 1,460 citations2021: 1,182 citations2022: 1,005 citations2023: 685 citations2024: 965 citations2025: 451 citations2026: 8 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,582 citing papers, 13.7% of this breakdownIndia: 1,261 citing papers, 10.9% of this breakdownChina: 1,189 citing papers, 10.3% of this breakdownGermany: 727 citing papers, 6.3% of this breakdownUnited Kingdom: 460 citing papers, 4% of this breakdownItaly: 447 citing papers, 3.9% of this breakdownIran: 406 citing papers, 3.5% of this breakdownEgypt: 337 citing papers, 2.9% of this breakdownFrance: 332 citing papers, 2.9% of this breakdownPortugal: 329 citing papers, 2.9% of this breakdownBrazil: 320 citing papers, 2.8% of this breakdownSpain: 311 citing papers, 2.7% of this breakdown
0%13.7%Other 33.2%

Fields

  • Pharmacology, Toxicology and Pharmaceutics30.7%
  • Materials Science17.2%
  • Biochemistry, Genetics and Molecular Biology16.3%
  • Medicine16%
  • Agricultural and Biological Sciences4.8%
  • Engineering4.1%
  • Other10.9%

Topics

  • Advancements in Transdermal Drug Delivery10%
  • Advanced Drug Delivery Systems8.5%
  • Nanoparticle-Based Drug Delivery7.1%
  • Drug Solubulity and Delivery Systems4.1%
  • RNA Interference and Gene Delivery4%
  • Lipid Membrane Structure and Behavior4%
  • Other62.3%

Coauthors

All papers

Open in search
  1. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) in Cosmetic and Dermatological Preparations

    Authors: , , - Advanced Drug Delivery Reviews 2002 cited by 2,065

  2. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products

    Authors: , , - International Journal of Pharmaceutics 2008 cited by 1,435

  3. Nanostructured lipid matrices for improved microencapsulation of drugs

    Authors: , , - International Journal of Pharmaceutics 2002 cited by 1,200

  4. ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption

    Authors: , , , , , , , - Colloids and Surfaces B Biointerfaces 2000 cited by 1,697

  5. Bottom-up approaches for preparing drug nanocrystals: Formulations and factors affecting particle size

    Authors: , , - International Journal of Pharmaceutics 2013 cited by 515

  6. State of the art of nanocrystals – Special features, production, nanotoxicology aspects and intracellular delivery

    Authors: , , - European Journal of Pharmaceutics and Biopharmaceutics 2011 cited by 695

  7. Nanosuspensions as particulate drug formulations in therapy

    Authors: , , - Advanced Drug Delivery Reviews 2001 cited by 1,361

  8. Nanocrystal technology, drug delivery and clinical applications

    Authors: , - International Journal of Nanomedicine 2008 cited by 941

  9. Solid lipid nanoparticles for parenteral drug delivery

    Authors: , , - Advanced Drug Delivery Reviews 2004 cited by 1,476

  10. 20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications

    Authors: , , - Current Drug Discovery Technologies 2011 cited by 525

  11. Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives

    Authors: , - International Journal of Pharmaceutics 2010 cited by 735

  12. Maturation of the matrix and viral membrane of HIV-1

    Authors: , , , , , , , , , , - Science 2021 cited by 112

  13. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions

    Authors: , - International Journal of Pharmaceutics 1998 cited by 676

  14. Challenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticles

    Authors: , - Journal of Biotechnology 2004 cited by 814

  15. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery

    Authors: , , , - International Journal of Pharmaceutics 2004 cited by 665

  16. Future quantum workforce: Competences, requirements, and forecasts

    Authors: , , , , - Physical Review Physics Education Research 2023 cited by 71

  17. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization

    Authors: , , , - Journal of Controlled Release 1994 cited by 568

  18. Lipid nanocarriers for dermal delivery of lutein: Preparation, characterization, stability and performance

    Authors: , , , , - International Journal of Pharmaceutics 2011 cited by 397

  19. Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery

    Authors: , , - Drug Development and Industrial Pharmacy 2008 cited by 386

  20. Formulation development of lipid nanoparticles: Improved lipid screening and development of tacrolimus loaded nanostructured lipid carriers (NLC)

    Authors: , , - International Journal of Pharmaceutics 2019 cited by 89

  21. Polymorphic behaviour of Compritol®888 ATO as bulk lipid and as SLN and NLC

    Authors: , , - Journal of Microencapsulation 2006 cited by 198

  22. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres

    Authors: , , , , , , - Advanced Drug Delivery Reviews 1995 cited by 808

  23. Production and Characterization of a Budesonide Nanosuspension for Pulmonary Administration

    Authors: , - Pharmaceutical Research 2002 cited by 439

  24. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q10 – Development, physicochemical characterization and in vitro release studies

    Authors: , , , - European Journal of Pharmaceutics and Biopharmaceutics 2007 cited by 319